TITXF News Alert Titan Medical Inc (TITXF) 1.5000 02/15/2015
Post# of 64074
Posted On: 02/15/2015 4:51:28 PM
Titan Medical Inc (TITXF) 1.5000 $TITXF
Titan Medical Inc. Announces Results for Fiscal Year Ended December 31, 2014
Marketwired - Tue Feb 10, 4:38PM CST
Titan Medical Inc. ("Titan" or the "Company"
(TSX: TMD) (OTCQX: TITXF) today announced financial results for the fiscal year ended December 31, 2014. All financial results are reported in U.S. dollars, unless otherwise stated.
TMD.TO: 1.84 (-0.04)
Titan Medical Inc. to Participate in the BTIG Second Annual Snowbird Medical Technology, Diagnostics and Healthcare IT Conference
Marketwire Canada - Mon Feb 09, 3:30PM CST
Titan Medical Inc. ("Titan" or the "Company" (TSX: TMD) (OTCQX: TITXF) today announced that John Hargrove, Chairman and Chief Executive Officer, and Dr. Reiza Rayman, President, will participate in the BTIG Second Annual Snowbird Medical Technology, Diagnostics and Healthcare IT Conference on Wednesday, February 18, 2015.
TMD.TO: 1.84 (-0.04)
Intuitive Surgical Set To Regain Momentum In 2015
Stephen Simpson, CFA - at Seeking Alpha - Mon Jan 26, 12:00PM CST
ISRG: 510.73 (+3.02), JNJ: 99.62 (+1.18), COV: 106.71 (-1.36), TRXC: 2.86 (-0.11), SYK: 94.51 (+1.14)
Why Titan Is Even More Attractive Now Than It Was Prior To Delaying Its SPORT Unit
Point Of Return - at Seeking Alpha - Thu Jan 15, 8:05AM CST
ISRG: 510.73 (+3.02), TRXC: 2.86 (-0.11)
Global Medical Robotics Market 2014-2020: Orthopedic, Neurology, Laparoscopy - Surgical Robot, Rehabilitation Robotics, Telemedicine, Assistive Robots, Orthotics, Prosthetics, Radio Surgery, Exoskeleton
M2 - Wed Jan 07, 8:44AM CST
Research and Markets (http://www.researchandmarkets.com/research/clshb9/global_medical) has announced the addition of the "Global Medical Robotics Market by Application, Type - Segmentation and Forecast 2014-2020" report to their offering. Advances in healthcare technology over the years have showed tremendous growth. From surgical devices to radio imaging and treatment methods, all aspects of medicines have taken technological leaps in the recent decades, making healthcare technology one of the most lucrative markets. The demand for robotics in healthcare, especially surgical procedures is increasing. Robotic procedures are deemed safer in situations where humans might make errors, as robotic procedures have far greater precision and leave minimum margin for error, and therefore having robotic systems in a hospital would be able to generate more revenue. Robots can also create better clinical outcomes and curtail labour costs, leading to an exponential growth in demand. However, surgery is not the only field with robotic advancements. Robotic panels are found in all segments of healthcare, such as sanitation and for disinfecting purposes, sterilization of instruments, processing laboratory supplies and other fields where technology aids and can replace human effort. Robotics in medicine is viewed as an all-round technological advancement, which is not limited to only one section. This is potentially the biggest leap in technology for the healthcare industry since the introduction of IT and has the scope of commercially being a vibrant industry with extensive chains of supply, production and R&D development. Key Topics Covered: 1. Executive Summary 2. Healthcare robotics market overview 3. Market determinants 4. Market segmentation 5. Cost analysis 6. Market strategies 7. Market share 8. Geography analysis 9. Corporate profiles - Titan Medical Inc - Siemens Healthcare - Robotic Surgical Tech, Inc. - Medtronic, Inc. - Hitachi Medical Corp. - Hansen Medical, Inc - Ge Healthcare - Immersion Corp. - Mako Surgical Corp - Mazor Robotics Ltd For more information visit http://www.researchandmarkets.com/research/cl...al_medical
MDT: 75.26 (+0.33), HNSN: 1.05 (+0.02), IMMR: 9.01 (-0.09), MZOR: 11.79 (+0.16)
Global Medical Robotics Market 2014-2020: Surgical Robot, Rehabilitation Robotics, Telemedicine, Assistive Robots, Orthotics, Prosthetics, Radio Surgery, Exoskeleton
M2 - Fri Dec 12, 2:53AM CST
Research and Markets (http://www.researchandmarkets.com/research/vg63ft/global_medical) has announced the addition of the "Global Medical Robotics Market by Application, Type - Segmentation and Forecast 2014-2020" report to their offering. Advances in healthcare technology over the years have showed tremendous growth. From surgical devices to radio imaging and treatment methods, all aspects of medicines have taken technological leaps in the recent decades, making healthcare technology one of the most lucrative markets. The demand for robotics in healthcare, especially surgical procedures is increasing. Robotic procedures are deemed safer in situations where humans might make errors, as robotic procedures have far greater precision and leave minimum margin for error, and therefore having robotic systems in a hospital would be able to generate more revenue. Robots can also create better clinical outcomes and curtail labour costs, leading to an exponential growth in demand. However, surgery is not the only field with robotic advancements. Robotic panels are found in all segments of healthcare, such as sanitation and for disinfecting purposes, sterilization of instruments, processing laboratory supplies and other fields where technology aids and can replace human effort. Robotics in medicine is viewed as an all-round technological advancement, which is not limited to only one section. This is potentially the biggest leap in technology for the healthcare industry since the introduction of IT and has the scope of commercially being a vibrant industry with extensive chains of supply, production and R&D development. This technology, however, is limited to economies that are invested in medical care to a great extent. For instance, the possibility of investment into robotic arms to enhance surgical procedure in public hospitals in a developing country such as Ghana is unlikely but the developed economies of North America and Europe are the most lucrative markets for medical robotics as they have significantly invested in healthcare. However; Asian countries such as India and China are the markets of the future as the governments of these coutries are putting in efforts to improve healthcare and the economies will show a significant growth. Key Topics Covered: 1. Executive summery 2. Healthcare robotics market overview 3. Market determinants 4. Market segmentation 5. Cost analysis 6. Market strategies 7. Market share 8. Geography analysis 9. Corporate profiles - Titan Medical Inc - Siemens Healthcare - Robotic Surgical Tech, Inc. - Medtronic, Inc. - Hitachi Medical Corp. - Hansen Medical, Inc - Ge Healthcare - Immersion Corp. - Mako Surgical Corp - Mazor Robotics Ltd For more information visit http://www.researchandmarkets.com/research/vg...al_medical
MDT: 75.26 (+0.33), HNSN: 1.05 (+0.02), IMMR: 9.01 (-0.09), MZOR: 11.79 (+0.16)
Market Maker Surveillance Report. SSI, DL, EBR, TITXF, BODY, AGIO, Winning Stocks With Lowest Price Friction For Wednesday, November 19th 2014
M2 - Thu Nov 20, 3:42AM CST
BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Wednesday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Wednesday there were 4516 companies with "abnormal" market making, 1857 companies with positive Friction Factors and 3256 companies with negative Friction Factors. Here is a list of the top companies with the largest percentage gain per share Wednesday and low price friction (bullish). This means that there was more buying than selling in the stocks and their stock prices rose faster with less Friction. STAGE STORES, INC. (NYSE:SSI), Danier Leather Inc (NYSE
L), Centrais Eletricas Brasileiras SA (NYSE:EBR), TITAN MEDICAL INC (OTC:TITXF), Body Central Corp (OTC:BODY), (NASDAQ:AGIO). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net .
DL: 18.44 (+0.60), SSI: 21.99 (+1.14), EBR: 1.81 (unch), AGIO: 118.55 (+0.11)
OTC Daily Alert Stock Watch - Titan Medical Inc. (TSX VENTURE:TMD) (OTCQX:TITXF)
WorldStockWire - Fri Nov 14, 11:30AM CST
OTC Daily Alert tracks stocks daily and is pleased to offer features on public companies. Investors can receive FREE Stock Alerts and company news and profiles by visiting OTC Daily Alert at the following: http://www.otcdailyalert.com
TMD.VN: 2.440 (+0.070)
Titan Medical Inc. Announces Results for the Three and Nine Months Ended September 30, 2014
Marketwired - Fri Nov 14, 6:01AM CST
Titan Medical Inc. ("Titan" or the "Company" (TSX: TMD) (OTCQX: TITXF) today announced financial results for the three and nine months ended September 30, 2014. All financial results are reported in U.S. dollars, unless otherwise stated.
TMD.TO: 1.84 (-0.04)
Titan Medical Inc. Announces Receipt of Final Approval to Graduate to TSX
Marketwire - Mon Sep 29, 6:01AM CDT
Titan Medical Inc. ("Titan" or the "Company" (TSX VENTURE: TMD) (OTCQX: TITXF) today announced that, effective at market opening on September 30, 2014, Titan's common shares and warrants will commence trading on the Toronto Stock Exchange ("TSX" . Concurrent with the TSX listing, the Company's common shares and warrants will be de-listed from the TSX Venture Exchange.
TMD.VN: 2.440 (+0.070)
Titan Medical Inc. Announces the Formation of Its Surgeon Advisory Board
Marketwire - Thu Sep 25, 6:01AM CDT
Titan Medical Inc. ("Titan" or the "Company" (TSX VENTURE: TMD)(OTCQX: TITXF) today announced that it has formed a Surgeon Advisory Board (SAB) that includes seven industry-renowned surgeons who specialize in minimally invasive procedures.
TMD.VN: 2.440 (+0.070)
Titan Medical Inc. Appoints Dr. Dennis Fowler as Executive Vice President, Clinical and Regulatory Affairs
Marketwire - Tue Sep 09, 6:03AM CDT
Titan Medical Inc. ("Titan" or the "Company" (TSX VENTURE: TMD)(OTCQX: TITXF) today announced that Dr. Dennis Fowler, who currently serves as the Company's Director of Clinical Affairs, has been appointed to the newly-created position of Executive Vice President, Clinical and Regulatory Affairs.
TMD.VN: 2.440 (+0.070)
Titan Medical Inc. Announces DTC Eligibility
Marketwire - Wed Sep 03, 6:01AM CDT
Titan Medical Inc. ("Titan" or the "Company" (TSX VENTURE: TMD)(OTCQX: TITXF) announced today that the Depository Trust Company (DTC) has approved the Company's eligibility application for Titan Medical Inc. (CUSIP 88830X108), effective August 21, 2014.
TMD.VN: 2.440 (+0.070)
Titan Medical Inc. Announces Results for the Three and Six Months Ended June 30, 2014
Marketwire - Wed Aug 13, 8:46AM CDT
Titan Medical Inc. ("Titan" or the "Company" (TSX VENTURE: TMD)(OTCQX: TITXF) announced today financial results for the three and six months ended June 30, 2014. All financial results are reported in U.S. dollars, unless otherwise stated.
TMD.VN: 2.440 (+0.070)
Titan Medical Inc. Announces Results for Fiscal Year Ended December 31, 2014
Marketwired - Tue Feb 10, 4:38PM CST
Titan Medical Inc. ("Titan" or the "Company"
(TSX: TMD) (OTCQX: TITXF) today announced financial results for the fiscal year ended December 31, 2014. All financial results are reported in U.S. dollars, unless otherwise stated. TMD.TO: 1.84 (-0.04)
Titan Medical Inc. to Participate in the BTIG Second Annual Snowbird Medical Technology, Diagnostics and Healthcare IT Conference
Marketwire Canada - Mon Feb 09, 3:30PM CST
Titan Medical Inc. ("Titan" or the "Company"
(TSX: TMD) (OTCQX: TITXF) today announced that John Hargrove, Chairman and Chief Executive Officer, and Dr. Reiza Rayman, President, will participate in the BTIG Second Annual Snowbird Medical Technology, Diagnostics and Healthcare IT Conference on Wednesday, February 18, 2015. TMD.TO: 1.84 (-0.04)
Intuitive Surgical Set To Regain Momentum In 2015
Stephen Simpson, CFA - at Seeking Alpha - Mon Jan 26, 12:00PM CST
ISRG: 510.73 (+3.02), JNJ: 99.62 (+1.18), COV: 106.71 (-1.36), TRXC: 2.86 (-0.11), SYK: 94.51 (+1.14)
Why Titan Is Even More Attractive Now Than It Was Prior To Delaying Its SPORT Unit
Point Of Return - at Seeking Alpha - Thu Jan 15, 8:05AM CST
ISRG: 510.73 (+3.02), TRXC: 2.86 (-0.11)
Global Medical Robotics Market 2014-2020: Orthopedic, Neurology, Laparoscopy - Surgical Robot, Rehabilitation Robotics, Telemedicine, Assistive Robots, Orthotics, Prosthetics, Radio Surgery, Exoskeleton
M2 - Wed Jan 07, 8:44AM CST
Research and Markets (http://www.researchandmarkets.com/research/clshb9/global_medical) has announced the addition of the "Global Medical Robotics Market by Application, Type - Segmentation and Forecast 2014-2020" report to their offering. Advances in healthcare technology over the years have showed tremendous growth. From surgical devices to radio imaging and treatment methods, all aspects of medicines have taken technological leaps in the recent decades, making healthcare technology one of the most lucrative markets. The demand for robotics in healthcare, especially surgical procedures is increasing. Robotic procedures are deemed safer in situations where humans might make errors, as robotic procedures have far greater precision and leave minimum margin for error, and therefore having robotic systems in a hospital would be able to generate more revenue. Robots can also create better clinical outcomes and curtail labour costs, leading to an exponential growth in demand. However, surgery is not the only field with robotic advancements. Robotic panels are found in all segments of healthcare, such as sanitation and for disinfecting purposes, sterilization of instruments, processing laboratory supplies and other fields where technology aids and can replace human effort. Robotics in medicine is viewed as an all-round technological advancement, which is not limited to only one section. This is potentially the biggest leap in technology for the healthcare industry since the introduction of IT and has the scope of commercially being a vibrant industry with extensive chains of supply, production and R&D development. Key Topics Covered: 1. Executive Summary 2. Healthcare robotics market overview 3. Market determinants 4. Market segmentation 5. Cost analysis 6. Market strategies 7. Market share 8. Geography analysis 9. Corporate profiles - Titan Medical Inc - Siemens Healthcare - Robotic Surgical Tech, Inc. - Medtronic, Inc. - Hitachi Medical Corp. - Hansen Medical, Inc - Ge Healthcare - Immersion Corp. - Mako Surgical Corp - Mazor Robotics Ltd For more information visit http://www.researchandmarkets.com/research/cl...al_medical
MDT: 75.26 (+0.33), HNSN: 1.05 (+0.02), IMMR: 9.01 (-0.09), MZOR: 11.79 (+0.16)
Global Medical Robotics Market 2014-2020: Surgical Robot, Rehabilitation Robotics, Telemedicine, Assistive Robots, Orthotics, Prosthetics, Radio Surgery, Exoskeleton
M2 - Fri Dec 12, 2:53AM CST
Research and Markets (http://www.researchandmarkets.com/research/vg63ft/global_medical) has announced the addition of the "Global Medical Robotics Market by Application, Type - Segmentation and Forecast 2014-2020" report to their offering. Advances in healthcare technology over the years have showed tremendous growth. From surgical devices to radio imaging and treatment methods, all aspects of medicines have taken technological leaps in the recent decades, making healthcare technology one of the most lucrative markets. The demand for robotics in healthcare, especially surgical procedures is increasing. Robotic procedures are deemed safer in situations where humans might make errors, as robotic procedures have far greater precision and leave minimum margin for error, and therefore having robotic systems in a hospital would be able to generate more revenue. Robots can also create better clinical outcomes and curtail labour costs, leading to an exponential growth in demand. However, surgery is not the only field with robotic advancements. Robotic panels are found in all segments of healthcare, such as sanitation and for disinfecting purposes, sterilization of instruments, processing laboratory supplies and other fields where technology aids and can replace human effort. Robotics in medicine is viewed as an all-round technological advancement, which is not limited to only one section. This is potentially the biggest leap in technology for the healthcare industry since the introduction of IT and has the scope of commercially being a vibrant industry with extensive chains of supply, production and R&D development. This technology, however, is limited to economies that are invested in medical care to a great extent. For instance, the possibility of investment into robotic arms to enhance surgical procedure in public hospitals in a developing country such as Ghana is unlikely but the developed economies of North America and Europe are the most lucrative markets for medical robotics as they have significantly invested in healthcare. However; Asian countries such as India and China are the markets of the future as the governments of these coutries are putting in efforts to improve healthcare and the economies will show a significant growth. Key Topics Covered: 1. Executive summery 2. Healthcare robotics market overview 3. Market determinants 4. Market segmentation 5. Cost analysis 6. Market strategies 7. Market share 8. Geography analysis 9. Corporate profiles - Titan Medical Inc - Siemens Healthcare - Robotic Surgical Tech, Inc. - Medtronic, Inc. - Hitachi Medical Corp. - Hansen Medical, Inc - Ge Healthcare - Immersion Corp. - Mako Surgical Corp - Mazor Robotics Ltd For more information visit http://www.researchandmarkets.com/research/vg...al_medical
MDT: 75.26 (+0.33), HNSN: 1.05 (+0.02), IMMR: 9.01 (-0.09), MZOR: 11.79 (+0.16)
Market Maker Surveillance Report. SSI, DL, EBR, TITXF, BODY, AGIO, Winning Stocks With Lowest Price Friction For Wednesday, November 19th 2014
M2 - Thu Nov 20, 3:42AM CST
BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Wednesday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Wednesday there were 4516 companies with "abnormal" market making, 1857 companies with positive Friction Factors and 3256 companies with negative Friction Factors. Here is a list of the top companies with the largest percentage gain per share Wednesday and low price friction (bullish). This means that there was more buying than selling in the stocks and their stock prices rose faster with less Friction. STAGE STORES, INC. (NYSE:SSI), Danier Leather Inc (NYSE
L), Centrais Eletricas Brasileiras SA (NYSE:EBR), TITAN MEDICAL INC (OTC:TITXF), Body Central Corp (OTC:BODY), (NASDAQ:AGIO). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net . DL: 18.44 (+0.60), SSI: 21.99 (+1.14), EBR: 1.81 (unch), AGIO: 118.55 (+0.11)
OTC Daily Alert Stock Watch - Titan Medical Inc. (TSX VENTURE:TMD) (OTCQX:TITXF)
WorldStockWire - Fri Nov 14, 11:30AM CST
OTC Daily Alert tracks stocks daily and is pleased to offer features on public companies. Investors can receive FREE Stock Alerts and company news and profiles by visiting OTC Daily Alert at the following: http://www.otcdailyalert.com
TMD.VN: 2.440 (+0.070)
Titan Medical Inc. Announces Results for the Three and Nine Months Ended September 30, 2014
Marketwired - Fri Nov 14, 6:01AM CST
Titan Medical Inc. ("Titan" or the "Company"
(TSX: TMD) (OTCQX: TITXF) today announced financial results for the three and nine months ended September 30, 2014. All financial results are reported in U.S. dollars, unless otherwise stated. TMD.TO: 1.84 (-0.04)
Titan Medical Inc. Announces Receipt of Final Approval to Graduate to TSX
Marketwire - Mon Sep 29, 6:01AM CDT
Titan Medical Inc. ("Titan" or the "Company"
(TSX VENTURE: TMD) (OTCQX: TITXF) today announced that, effective at market opening on September 30, 2014, Titan's common shares and warrants will commence trading on the Toronto Stock Exchange ("TSX" . Concurrent with the TSX listing, the Company's common shares and warrants will be de-listed from the TSX Venture Exchange. TMD.VN: 2.440 (+0.070)
Titan Medical Inc. Announces the Formation of Its Surgeon Advisory Board
Marketwire - Thu Sep 25, 6:01AM CDT
Titan Medical Inc. ("Titan" or the "Company"
(TSX VENTURE: TMD)(OTCQX: TITXF) today announced that it has formed a Surgeon Advisory Board (SAB) that includes seven industry-renowned surgeons who specialize in minimally invasive procedures. TMD.VN: 2.440 (+0.070)
Titan Medical Inc. Appoints Dr. Dennis Fowler as Executive Vice President, Clinical and Regulatory Affairs
Marketwire - Tue Sep 09, 6:03AM CDT
Titan Medical Inc. ("Titan" or the "Company"
(TSX VENTURE: TMD)(OTCQX: TITXF) today announced that Dr. Dennis Fowler, who currently serves as the Company's Director of Clinical Affairs, has been appointed to the newly-created position of Executive Vice President, Clinical and Regulatory Affairs. TMD.VN: 2.440 (+0.070)
Titan Medical Inc. Announces DTC Eligibility
Marketwire - Wed Sep 03, 6:01AM CDT
Titan Medical Inc. ("Titan" or the "Company"
(TSX VENTURE: TMD)(OTCQX: TITXF) announced today that the Depository Trust Company (DTC) has approved the Company's eligibility application for Titan Medical Inc. (CUSIP 88830X108), effective August 21, 2014. TMD.VN: 2.440 (+0.070)
Titan Medical Inc. Announces Results for the Three and Six Months Ended June 30, 2014
Marketwire - Wed Aug 13, 8:46AM CDT
Titan Medical Inc. ("Titan" or the "Company"
(TSX VENTURE: TMD)(OTCQX: TITXF) announced today financial results for the three and six months ended June 30, 2014. All financial results are reported in U.S. dollars, unless otherwise stated. TMD.VN: 2.440 (+0.070)
(0)
(0)Scroll down for more posts ▼